Loss-of-function techniques, such as RNAi and CRISPR, are widely used for gene silencing. These experimental methods have been extensively applied in establishing gene function in biological processes, identification of therapeutic drug targets and vulnerabilities of cancer cells. In this talk, I will describe about statistical methods that are used to analyse genome-wide loss-of-function datasets.